Reports
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States
Americas
Future Market Insights, Inc.
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
MEA
Future Market Insights
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom
Asia Pacific
Future Market Insights
IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India
[250 Pages Report] The pharmaceuticals excipients market is expected to register a CAGR of 6% during the forecast period, up from US$ 7.9 Billion in 2021 to reach a valuation of US$ 10.9 Billion by 2026.
Report Attributes | Details |
---|---|
bEstimated Base Year Value (2021) | US$ 7.9 Billion |
Expected Market Value (2026) | US$ 10.9 Billion |
Projected Growth Rate (2022 to 2032) | 6% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Over the forecast period, the pharmaceuticals excipients market is expected to exhibit a similar trend to that of North America, where it holds the majority share. The growth of the market will be primarily driven by factors such as the fast-growing pharmaceutical industry, the increasing demand for functional excipients, the presence of major players in the region, and technological advances.
Furthermore, the introduction of technologically advanced or superior excipients is also one of the factors driving the growth of this market. Accordingly, Lubrizol Life Science (LLS) Health, one of the world's leading companies in accelerating success and innovation in pharmaceutical development, launched Apisolex for the first time in May 2022.
This excipient is a novel solubility-enhancing excipient that can be used in parenteral drug products. By utilizing this technology, we can overcome solubility hurdles that cannot be overcome by existing excipients or manufacturing processes.
The global sales of pharmaceutical excipients are driven by factors such as growing demand for functional excipients, increasing demand for generics, and the emergence of new excipients in the market.
Thousands of different excipients are used in medicines and makeup, on average, about 90% of each product. As a result, they represent a market value accounting for about 0.5% of the total demand for pharmaceutical excipients.
The sales of pharmaceutical excipients are expected to grow at a healthy CAGR during the forecast period due to increasing utilization of parenteral products due to the rise in the global burden of chronic and lifestyle diseases and heavy investments by the pharmaceuticals industry in the development of biologics.
Additionally, the adoption of modern science like nanotechnology to impart innovative functions to the excipients used for target-specific functionality of the active ingredients, resulting in reduced drug toxicity, a major challenge faced by the pharmaceutical industry, is also propelling the demand for pharmaceutical excipients during the forecast period.
The product demand is increasing in emerging markets like Asia-Pacific and Latin America; therefore, proper expansion planning focuses on various R&D and innovations to launch new products would be a great opportunity.
The sales of pharmaceutical excipients are hampered to a certain extent by the factors like declining investments in R&D by excipients producers and increasing regulatory requirements leading to scarcity of U.S. FDA-approved manufacturing sites.
Due to technological advancements, the growing investments into the development of biologics and superior dosage forms, and the presence of key players in the region, Europe is expected to show significant growth in the global pharmaceuticals excipients market in the forecasted period.
The large share of this region can be attributed to the presence of many pharmaceutical giants with large production capacities leading to the high consumption of excipients in this region. Due to the increasing emphasis on superior pharmaceutical products, generics, and biosimilars, the demand for novel excipients has also risen, and this trend is expected to drive the growth of the market.
It has been estimated that in 2020, the production of pharmaceuticals in the European region was valued at EUR 286,697 million. In 2021, it will be valued at EUR 300,000 million, according to the report from the European Federation of Pharmaceutical Industries and Associations 2022.
An increase in the value of production is often accompanied by an increase in the number of pharmaceuticals produced, which, in turn, boosts the demand for pharmaceuticals excipients. Furthermore, it is predicted that the market may continue to grow as a result of the expansion of facilities by the market players to develop high-performance ingredients.
Croda International Plc opened a new high-purity excipient manufacturing facility in Mill Hall, London in July 2021. The investment led Croda to develop innovative pharmaceutical excipients for use in smart science as a result of the investment.
Sales of pharmaceuticals excipients are expected to rise due to the significant research and development taking place in the industry. In addition to this, demand for pharmaceutical excipients is rising on account of the fast-increasing biopharmaceuticals sector and the rising acceptance of orphan medications.
Increasing demand for functionality excipients is also projected to contribute to the growth of the pharmaceuticals excipients market share.
The report sheds light on the factors improving the sales of pharmaceuticals excipients and, in turn, the opportunities for the market players. However, the pharmaceuticals excipients market also faces some challenges, which might limit the pharmaceuticals excipients market share from reaching its potential.
Some of the key pharmaceuticals excipients market trends promoting the demand for pharmaceuticals excipients include a strong pharmaceutical manufacturing presence in various emerging countries, which is projected to give profitable growth prospects for the pharmaceutical excipients market share throughout time.
As a result, they offer great efficiency and fewer adverse effects. As a result, they are one of the pharmaceutical excipients market's fastest-growing segments. In addition, cell therapy (for cancer treatment) and gene therapy (for regenerative medicine) are two new concepts that are constantly being developed. This creates a compelling chance for the pharmaceutical excipients market to expand further.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The global pharmaceutical excipients market is sub-segmented into 7 key regions- North America, Latin America, East Europe, West Europe, Asia Pacific, and Middle East & Africa.
Developed regions like North America and Europe are expected to experience slow growth in sales of pharmaceutical excipients, due to already established excipients market, during the forecast period while the emerging market like Asia-Pacific is expected to record strong growth during the same period owing to the availability of cheap labor, skills in abundance, strong demand for pharmaceutical excipients and comparatively lower cost of raw materials.
Countries like Brazil, India, and China are expected to be the major contributors in the sales of pharmaceutical excipients in the emerging markets mainly due to the rising per capita income and increase in the number of companies from the developed regions willing to outsource their excipients manufacturing activities due to low manufacturing and labor costs in these regions. In addition, the rising disposable income in this region is also driving the demand for pharmaceutical excipients.
Major players in the pharmaceutical excipients market are BASF (Germany) and Ashland, Inc. (U.S.), which dominate the sales of pharmaceutical excipients with their diversified product portfolio and aggressive sales strategies.
Some other key players include Avantor Performance Materials, Inc. (U.S.), The Dow Chemical Company (U.S.), FMC Corporation (U.S.), Evonik Industries (Germany), Lubrizol Corporation (U.S.), Roquette (France), and Colorcon, Inc. (U.S.)
Business expansions, new product launches, mergers & acquisitions, and collaborations with educational universities are the key strategies most companies adapt to cater to the growing demand for pharmaceutical excipients.
The need for innovative functional excipients in the pharmaceutical industry will lead to innovations in the market, further leading to better sales of pharmaceutical excipients during the forecast period.
Owing to this strategy, leading players continuously introduce several advanced excipients and modified categories of existing excipients in the market.
Report Attributes | Details |
---|---|
Growth rate | CAGR of 6% from 2022 to 2032 |
Base year for estimation | 2021 |
Historical data | 2015 to 2020 |
Forecast period | 2022 to 2032 |
Quantitative units | Revenue in US$ million and CAGR from 2022 to 2032 |
Report coverage | Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis, |
Segments covered | Functionality, region |
Regional scope | North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia and New Zealand |
Country scope | USA; Canada; Mexico; Germany; UK; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; UAE; Iran; South Africa |
Key companies profiled | Ashland Global Holdings, Croda International, BASF SE, Lubrizol Corporation, Evonik Industries AG, Associated British Foods, Roquette Feres, Archer Daniels Midland Company, and DuPont. |
Customization scope | Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options | Avail customized purchase options to meet your exact research needs. |
The market is likely to register a CAGR of 6% through 2032.
The market is currently valued at US$ 7.9 Bn in 2021.
The market is likely to grow to a valuation of US$ 10.9 Bn by 2026.
North America is likely to be a leading market during the forecast period.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. Value Chain Analysis 3.5.1. Profit Margin Analysis 3.5.2. Service Providers 3.6. PESTLE and Porter’s Analysis 3.7. Regulatory Landscape 3.7.1. By Key Regions 3.7.2. By Key Countries 3.8. Regional Parent Market Outlook 4. Global Market Analysis 2017-2021 and Forecast, 2022-2032 4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Chemical Nature 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Mn) Analysis By Chemical Nature, 2017-2021 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Chemical Nature, 2022-2032 5.3.1. Natural Polysaccharides Polymers 5.3.2. Semi-synthetic Polymers 5.3.3. Synthetic Polymers 5.3.4. Inorganic Excipients 5.3.5. Sugar Compounds 5.4. Y-o-Y Growth Trend Analysis By Chemical Nature, 2017-2021 5.5. Absolute $ Opportunity Analysis By Chemical Nature, 2022-2032 Deep-dive segmentation will be available in the sample on request 6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Dosage Type 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Mn) Analysis By Dosage Type, 2017-2021 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Dosage Type, 2022-2032 6.3.1. Oral Formulations 6.3.2. Parenteral Formulations 6.3.3. Topical Formulations 6.3.4. Ophthalmic Formulations 6.3.5. Nasal Formulations 6.3.6. Vaginal Formulations 6.3.7. Suppository Formulations 6.4. Y-o-Y Growth Trend Analysis By Dosage Type, 2017-2021 6.5. Absolute $ Opportunity Analysis By Dosage Type, 2022-2032 Deep-dive segmentation will be available in the sample on request 7. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Functionality 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Mn) Analysis By Functionality, 2017-2021 7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Functionality, 2022-2032 7.3.1. Diluents 7.3.2. Fillers 7.3.3. Binders 7.3.4. Disintegrants 7.3.5. Lubricants 7.3.6. Glidants 7.3.7. Coating Agents 7.3.8. Colouring Agents 7.3.9. Emulsifying Agents 7.3.10. Preservatives 7.3.11. Vehicles 7.3.12. Others 7.4. Y-o-Y Growth Trend Analysis By Functionality, 2017-2021 7.5. Absolute $ Opportunity Analysis By Functionality, 2022-2032 Deep-dive segmentation will be available in the sample on request 8. Global Market Analysis 2017-2021 and Forecast 2022-2032, By End User 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2017-2021 8.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032 8.3.1. Biotechnology and Pharmaceutical Companies 8.3.2. Contract Development and Manufacturing Organizations (CDMOs) 8.3.3. Research Laboratories 8.3.4. Others 8.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021 8.5. Absolute $ Opportunity Analysis By End User, 2022-2032 Deep-dive segmentation will be available in the sample on request 9. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region 9.1. Introduction 9.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021 9.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032 9.3.1. North America 9.3.2. Latin America 9.3.3. Europe 9.3.4. East Asia 9.3.5. South Asia & Pacific 9.3.6. MEA 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 10.2.1. By Country 10.2.1.1. U.S. 10.2.1.2. Canada 10.2.2. By Chemical Nature 10.2.3. By Dosage Type 10.2.4. By Functionality 10.2.5. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Chemical Nature 10.3.3. By Dosage Type 10.3.4. By Functionality 10.3.5. By End User 10.4. Key Takeaways 11. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 11.2.1. By Country 11.2.1.1. Mexico 11.2.1.2. Brazil 11.2.1.3. Rest of Latin America 11.2.2. By Chemical Nature 11.2.3. By Dosage Type 11.2.4. By Functionality 11.2.5. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Chemical Nature 11.3.3. By Dosage Type 11.3.4. By Functionality 11.3.5. By End User 11.4. Key Takeaways 12. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 12.2.1. By Country 12.2.1.1. Germany 12.2.1.2. Italy 12.2.1.3. France 12.2.1.4. U.K. 12.2.1.5. Spain 12.2.1.6. BENELUX 12.2.1.7. Russia 12.2.1.8. Rest of Europe 12.2.2. By Chemical Nature 12.2.3. By Dosage Type 12.2.4. By Functionality 12.2.5. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Chemical Nature 12.3.3. By Dosage Type 12.3.4. By Functionality 12.3.5. By End User 12.4. Key Takeaways 13. East Asia Market Analysis 2017-2021 and Forecast 2022-2032, By Country 13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 13.2.1. By Country 13.2.1.1. China 13.2.1.2. Japan 13.2.1.3. South Korea 13.2.2. By Chemical Nature 13.2.3. By Dosage Type 13.2.4. By Functionality 13.2.5. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Chemical Nature 13.3.3. By Dosage Type 13.3.4. By Functionality 13.3.5. By End User 13.4. Key Takeaways 14. South Asia & Pacific Market Analysis 2017-2021 and Forecast 2022-2032, By Country 14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 14.2.1. By Country 14.2.1.1. India 14.2.1.2. ASEAN 14.2.1.3. Australia and New Zealand 14.2.1.4. Rest of South Asia & Pacific 14.2.2. By Chemical Nature 14.2.3. By Dosage Type 14.2.4. By Functionality 14.2.5. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Chemical Nature 14.3.3. By Dosage Type 14.3.4. By Functionality 14.3.5. By End User 14.4. Key Takeaways 15. MEA Market Analysis 2017-2021 and Forecast 2022-2032, By Country 15.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 15.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. Turkey 15.2.1.3. South Africa 15.2.1.4. Rest of MEA 15.2.2. By Chemical Nature 15.2.3. By Dosage Type 15.2.4. By Functionality 15.2.5. By End User 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Chemical Nature 15.3.3. By Dosage Type 15.3.4. By Functionality 15.3.5. By End User 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. U.S. 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2021 16.1.2.1. By Chemical Nature 16.1.2.2. By Dosage Type 16.1.2.3. By Functionality 16.1.2.4. By End User 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2021 16.2.2.1. By Chemical Nature 16.2.2.2. By Dosage Type 16.2.2.3. By Functionality 16.2.2.4. By End User 16.3. Mexico 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2021 16.3.2.1. By Chemical Nature 16.3.2.2. By Dosage Type 16.3.2.3. By Functionality 16.3.2.4. By End User 16.4. Brazil 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2021 16.4.2.1. By Chemical Nature 16.4.2.2. By Dosage Type 16.4.2.3. By Functionality 16.4.2.4. By End User 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2021 16.5.2.1. By Chemical Nature 16.5.2.2. By Dosage Type 16.5.2.3. By Functionality 16.5.2.4. By End User 16.6. Italy 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2021 16.6.2.1. By Chemical Nature 16.6.2.2. By Dosage Type 16.6.2.3. By Functionality 16.6.2.4. By End User 16.7. France 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2021 16.7.2.1. By Chemical Nature 16.7.2.2. By Dosage Type 16.7.2.3. By Functionality 16.7.2.4. By End User 16.8. U.K. 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2021 16.8.2.1. By Chemical Nature 16.8.2.2. By Dosage Type 16.8.2.3. By Functionality 16.8.2.4. By End User 16.9. Spain 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2021 16.9.2.1. By Chemical Nature 16.9.2.2. By Dosage Type 16.9.2.3. By Functionality 16.9.2.4. By End User 16.10. BENELUX 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2021 16.10.2.1. By Chemical Nature 16.10.2.2. By Dosage Type 16.10.2.3. By Functionality 16.10.2.4. By End User 16.11. Russia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2021 16.11.2.1. By Chemical Nature 16.11.2.2. By Dosage Type 16.11.2.3. By Functionality 16.11.2.4. By End User 16.12. China 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2021 16.12.2.1. By Chemical Nature 16.12.2.2. By Dosage Type 16.12.2.3. By Functionality 16.12.2.4. By End User 16.13. Japan 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2021 16.13.2.1. By Chemical Nature 16.13.2.2. By Dosage Type 16.13.2.3. By Functionality 16.13.2.4. By End User 16.14. South Korea 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2021 16.14.2.1. By Chemical Nature 16.14.2.2. By Dosage Type 16.14.2.3. By Functionality 16.14.2.4. By End User 16.15. India 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2021 16.15.2.1. By Chemical Nature 16.15.2.2. By Dosage Type 16.15.2.3. By Functionality 16.15.2.4. By End User 16.16. ASEAN 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2021 16.16.2.1. By Chemical Nature 16.16.2.2. By Dosage Type 16.16.2.3. By Functionality 16.16.2.4. By End User 16.17. Australia and New Zealand 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2021 16.17.2.1. By Chemical Nature 16.17.2.2. By Dosage Type 16.17.2.3. By Functionality 16.17.2.4. By End User 16.18. GCC Countries 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2021 16.18.2.1. By Chemical Nature 16.18.2.2. By Dosage Type 16.18.2.3. By Functionality 16.18.2.4. By End User 16.19. Turkey 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2021 16.19.2.1. By Chemical Nature 16.19.2.2. By Dosage Type 16.19.2.3. By Functionality 16.19.2.4. By End User 16.20. South Africa 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2021 16.20.2.1. By Chemical Nature 16.20.2.2. By Dosage Type 16.20.2.3. By Functionality 16.20.2.4. By End User 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Chemical Nature 17.3.3. By Dosage Type 17.3.4. By Functionality 17.3.5. By End User 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Croda International 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.1.5.2. Product Strategy 18.1.1.5.3. Channel Strategy 18.1.2. Evonik Industries AG 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.2.5.2. Product Strategy 18.1.2.5.3. Channel Strategy 18.1.3. Innophos Holdings Inc. 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.3.5.2. Product Strategy 18.1.3.5.3. Channel Strategy 18.1.4. Roquette Pharma 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.4.5.2. Product Strategy 18.1.4.5.3. Channel Strategy 18.1.5. The Dow Chemical Company 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.5.5.2. Product Strategy 18.1.5.5.3. Channel Strategy 18.1.6. Wacker Chemie AG 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.6.5.2. Product Strategy 18.1.6.5.3. Channel Strategy 18.1.7. Paulaur Corporation 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.7.5.2. Product Strategy 18.1.7.5.3. Channel Strategy 18.1.8. Signet Excipients Pvt. Ltd 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.8.5.2. Product Strategy 18.1.8.5.3. Channel Strategy 18.1.9. Ashland, Inc. 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.9.5.2. Product Strategy 18.1.9.5.3. Channel Strategy 18.1.10. FMC Corporation 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 18.1.10.5.2. Product Strategy 18.1.10.5.3. Channel Strategy 18.1.11. Associated British Foods Plc. 18.1.11.1. Overview 18.1.11.2. Product Portfolio 18.1.11.3. Profitability by Market Segments 18.1.11.4. Sales Footprint 18.1.11.5. Strategy Overview 18.1.11.5.1. Marketing Strategy 18.1.11.5.2. Product Strategy 18.1.11.5.3. Channel Strategy 18.1.12. Archer Daniels Midland Company 18.1.12.1. Overview 18.1.12.2. Product Portfolio 18.1.12.3. Profitability by Market Segments 18.1.12.4. Sales Footprint 18.1.12.5. Strategy Overview 18.1.12.5.1. Marketing Strategy 18.1.12.5.2. Product Strategy 18.1.12.5.3. Channel Strategy 18.1.13. Lubrizol Corporation 18.1.13.1. Overview 18.1.13.2. Product Portfolio 18.1.13.3. Profitability by Market Segments 18.1.13.4. Sales Footprint 18.1.13.5. Strategy Overview 18.1.13.5.1. Marketing Strategy 18.1.13.5.2. Product Strategy 18.1.13.5.3. Channel Strategy 18.1.14. Avantor Performance Materials, Inc. 18.1.14.1. Overview 18.1.14.2. Product Portfolio 18.1.14.3. Profitability by Market Segments 18.1.14.4. Sales Footprint 18.1.14.5. Strategy Overview 18.1.14.5.1. Marketing Strategy 18.1.14.5.2. Product Strategy 18.1.14.5.3. Channel Strategy 18.1.15. NIPPON SODA CO., LTD. 18.1.15.1. Overview 18.1.15.2. Product Portfolio 18.1.15.3. Profitability by Market Segments 18.1.15.4. Sales Footprint 18.1.15.5. Strategy Overview 18.1.15.5.1. Marketing Strategy 18.1.15.5.2. Product Strategy 18.1.15.5.3. Channel Strategy 18.1.16. DFE Pharma 18.1.16.1. Overview 18.1.16.2. Product Portfolio 18.1.16.3. Profitability by Market Segments 18.1.16.4. Sales Footprint 18.1.16.5. Strategy Overview 18.1.16.5.1. Marketing Strategy 18.1.16.5.2. Product Strategy 18.1.16.5.3. Channel Strategy 18.1.17. Glatt GmbH 18.1.17.1. Overview 18.1.17.2. Product Portfolio 18.1.17.3. Profitability by Market Segments 18.1.17.4. Sales Footprint 18.1.17.5. Strategy Overview 18.1.17.5.1. Marketing Strategy 18.1.17.5.2. Product Strategy 18.1.17.5.3. Channel Strategy 18.1.18. Jost Chemical Co. 18.1.18.1. Overview 18.1.18.2. Product Portfolio 18.1.18.3. Profitability by Market Segments 18.1.18.4. Sales Footprint 18.1.18.5. Strategy Overview 18.1.18.5.1. Marketing Strategy 18.1.18.5.2. Product Strategy 18.1.18.5.3. Channel Strategy 18.1.19. ABITEC Corporation 18.1.19.1. Overview 18.1.19.2. Product Portfolio 18.1.19.3. Profitability by Market Segments 18.1.19.4. Sales Footprint 18.1.19.5. Strategy Overview 18.1.19.5.1. Marketing Strategy 18.1.19.5.2. Product Strategy 18.1.19.5.3. Channel Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Table 1: Global Market Value (US$ Mn) Forecast by Region, 2017-2032 Table 2: Global Market Value (US$ Mn) Forecast by Chemical Nature, 2017-2032 Table 3: Global Market Value (US$ Mn) Forecast by Dosage Type, 2017-2032 Table 4: Global Market Value (US$ Mn) Forecast by Functionality, 2017-2032 Table 5: Global Market Value (US$ Mn) Forecast by End User, 2017-2032 Table 6: North America Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 7: North America Market Value (US$ Mn) Forecast by Chemical Nature, 2017-2032 Table 8: North America Market Value (US$ Mn) Forecast by Dosage Type, 2017-2032 Table 9: North America Market Value (US$ Mn) Forecast by Functionality, 2017-2032 Table 10: North America Market Value (US$ Mn) Forecast by End User, 2017-2032 Table 11: Latin America Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 12: Latin America Market Value (US$ Mn) Forecast by Chemical Nature, 2017-2032 Table 13: Latin America Market Value (US$ Mn) Forecast by Dosage Type, 2017-2032 Table 14: Latin America Market Value (US$ Mn) Forecast by Functionality, 2017-2032 Table 15: Latin America Market Value (US$ Mn) Forecast by End User, 2017-2032 Table 16: Europe Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 17: Europe Market Value (US$ Mn) Forecast by Chemical Nature, 2017-2032 Table 18: Europe Market Value (US$ Mn) Forecast by Dosage Type, 2017-2032 Table 19: Europe Market Value (US$ Mn) Forecast by Functionality, 2017-2032 Table 20: Europe Market Value (US$ Mn) Forecast by End User, 2017-2032 Table 21: East Asia Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 22: East Asia Market Value (US$ Mn) Forecast by Chemical Nature, 2017-2032 Table 23: East Asia Market Value (US$ Mn) Forecast by Dosage Type, 2017-2032 Table 24: East Asia Market Value (US$ Mn) Forecast by Functionality, 2017-2032 Table 25: East Asia Market Value (US$ Mn) Forecast by End User, 2017-2032 Table 26: South Asia & Pacific Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 27: South Asia & Pacific Market Value (US$ Mn) Forecast by Chemical Nature, 2017-2032 Table 28: South Asia & Pacific Market Value (US$ Mn) Forecast by Dosage Type, 2017-2032 Table 29: South Asia & Pacific Market Value (US$ Mn) Forecast by Functionality, 2017-2032 Table 30: South Asia & Pacific Market Value (US$ Mn) Forecast by End User, 2017-2032 Table 31: MEA Market Value (US$ Mn) Forecast by Country, 2017-2032 Table 32: MEA Market Value (US$ Mn) Forecast by Chemical Nature, 2017-2032 Table 33: MEA Market Value (US$ Mn) Forecast by Dosage Type, 2017-2032 Table 34: MEA Market Value (US$ Mn) Forecast by Functionality, 2017-2032 Table 35: MEA Market Value (US$ Mn) Forecast by End User, 2017-2032
Figure 1: Global Market Value (US$ Mn) by Chemical Nature, 2022-2032 Figure 2: Global Market Value (US$ Mn) by Dosage Type, 2022-2032 Figure 3: Global Market Value (US$ Mn) by Functionality, 2022-2032 Figure 4: Global Market Value (US$ Mn) by End User, 2022-2032 Figure 5: Global Market Value (US$ Mn) by Region, 2022-2032 Figure 6: Global Market Value (US$ Mn) Analysis by Region, 2017-2032 Figure 7: Global Market Value Share (%) and BPS Analysis by Region, 2022-2032 Figure 8: Global Market Y-o-Y Growth (%) Projections by Region, 2022-2032 Figure 9: Global Market Value (US$ Mn) Analysis by Chemical Nature, 2017-2032 Figure 10: Global Market Value Share (%) and BPS Analysis by Chemical Nature, 2022-2032 Figure 11: Global Market Y-o-Y Growth (%) Projections by Chemical Nature, 2022-2032 Figure 12: Global Market Value (US$ Mn) Analysis by Dosage Type, 2017-2032 Figure 13: Global Market Value Share (%) and BPS Analysis by Dosage Type, 2022-2032 Figure 14: Global Market Y-o-Y Growth (%) Projections by Dosage Type, 2022-2032 Figure 15: Global Market Value (US$ Mn) Analysis by Functionality, 2017-2032 Figure 16: Global Market Value Share (%) and BPS Analysis by Functionality, 2022-2032 Figure 17: Global Market Y-o-Y Growth (%) Projections by Functionality, 2022-2032 Figure 18: Global Market Value (US$ Mn) Analysis by End User, 2017-2032 Figure 19: Global Market Value Share (%) and BPS Analysis by End User, 2022-2032 Figure 20: Global Market Y-o-Y Growth (%) Projections by End User, 2022-2032 Figure 21: Global Market Attractiveness by Chemical Nature, 2022-2032 Figure 22: Global Market Attractiveness by Dosage Type, 2022-2032 Figure 23: Global Market Attractiveness by Functionality, 2022-2032 Figure 24: Global Market Attractiveness by End User, 2022-2032 Figure 25: Global Market Attractiveness by Region, 2022-2032 Figure 26: North America Market Value (US$ Mn) by Chemical Nature, 2022-2032 Figure 27: North America Market Value (US$ Mn) by Dosage Type, 2022-2032 Figure 28: North America Market Value (US$ Mn) by Functionality, 2022-2032 Figure 29: North America Market Value (US$ Mn) by End User, 2022-2032 Figure 30: North America Market Value (US$ Mn) by Country, 2022-2032 Figure 31: North America Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 32: North America Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 33: North America Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 34: North America Market Value (US$ Mn) Analysis by Chemical Nature, 2017-2032 Figure 35: North America Market Value Share (%) and BPS Analysis by Chemical Nature, 2022-2032 Figure 36: North America Market Y-o-Y Growth (%) Projections by Chemical Nature, 2022-2032 Figure 37: North America Market Value (US$ Mn) Analysis by Dosage Type, 2017-2032 Figure 38: North America Market Value Share (%) and BPS Analysis by Dosage Type, 2022-2032 Figure 39: North America Market Y-o-Y Growth (%) Projections by Dosage Type, 2022-2032 Figure 40: North America Market Value (US$ Mn) Analysis by Functionality, 2017-2032 Figure 41: North America Market Value Share (%) and BPS Analysis by Functionality, 2022-2032 Figure 42: North America Market Y-o-Y Growth (%) Projections by Functionality, 2022-2032 Figure 43: North America Market Value (US$ Mn) Analysis by End User, 2017-2032 Figure 44: North America Market Value Share (%) and BPS Analysis by End User, 2022-2032 Figure 45: North America Market Y-o-Y Growth (%) Projections by End User, 2022-2032 Figure 46: North America Market Attractiveness by Chemical Nature, 2022-2032 Figure 47: North America Market Attractiveness by Dosage Type, 2022-2032 Figure 48: North America Market Attractiveness by Functionality, 2022-2032 Figure 49: North America Market Attractiveness by End User, 2022-2032 Figure 50: North America Market Attractiveness by Country, 2022-2032 Figure 51: Latin America Market Value (US$ Mn) by Chemical Nature, 2022-2032 Figure 52: Latin America Market Value (US$ Mn) by Dosage Type, 2022-2032 Figure 53: Latin America Market Value (US$ Mn) by Functionality, 2022-2032 Figure 54: Latin America Market Value (US$ Mn) by End User, 2022-2032 Figure 55: Latin America Market Value (US$ Mn) by Country, 2022-2032 Figure 56: Latin America Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 57: Latin America Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 58: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 59: Latin America Market Value (US$ Mn) Analysis by Chemical Nature, 2017-2032 Figure 60: Latin America Market Value Share (%) and BPS Analysis by Chemical Nature, 2022-2032 Figure 61: Latin America Market Y-o-Y Growth (%) Projections by Chemical Nature, 2022-2032 Figure 62: Latin America Market Value (US$ Mn) Analysis by Dosage Type, 2017-2032 Figure 63: Latin America Market Value Share (%) and BPS Analysis by Dosage Type, 2022-2032 Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Dosage Type, 2022-2032 Figure 65: Latin America Market Value (US$ Mn) Analysis by Functionality, 2017-2032 Figure 66: Latin America Market Value Share (%) and BPS Analysis by Functionality, 2022-2032 Figure 67: Latin America Market Y-o-Y Growth (%) Projections by Functionality, 2022-2032 Figure 68: Latin America Market Value (US$ Mn) Analysis by End User, 2017-2032 Figure 69: Latin America Market Value Share (%) and BPS Analysis by End User, 2022-2032 Figure 70: Latin America Market Y-o-Y Growth (%) Projections by End User, 2022-2032 Figure 71: Latin America Market Attractiveness by Chemical Nature, 2022-2032 Figure 72: Latin America Market Attractiveness by Dosage Type, 2022-2032 Figure 73: Latin America Market Attractiveness by Functionality, 2022-2032 Figure 74: Latin America Market Attractiveness by End User, 2022-2032 Figure 75: Latin America Market Attractiveness by Country, 2022-2032 Figure 76: Europe Market Value (US$ Mn) by Chemical Nature, 2022-2032 Figure 77: Europe Market Value (US$ Mn) by Dosage Type, 2022-2032 Figure 78: Europe Market Value (US$ Mn) by Functionality, 2022-2032 Figure 79: Europe Market Value (US$ Mn) by End User, 2022-2032 Figure 80: Europe Market Value (US$ Mn) by Country, 2022-2032 Figure 81: Europe Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 82: Europe Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 83: Europe Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 84: Europe Market Value (US$ Mn) Analysis by Chemical Nature, 2017-2032 Figure 85: Europe Market Value Share (%) and BPS Analysis by Chemical Nature, 2022-2032 Figure 86: Europe Market Y-o-Y Growth (%) Projections by Chemical Nature, 2022-2032 Figure 87: Europe Market Value (US$ Mn) Analysis by Dosage Type, 2017-2032 Figure 88: Europe Market Value Share (%) and BPS Analysis by Dosage Type, 2022-2032 Figure 89: Europe Market Y-o-Y Growth (%) Projections by Dosage Type, 2022-2032 Figure 90: Europe Market Value (US$ Mn) Analysis by Functionality, 2017-2032 Figure 91: Europe Market Value Share (%) and BPS Analysis by Functionality, 2022-2032 Figure 92: Europe Market Y-o-Y Growth (%) Projections by Functionality, 2022-2032 Figure 93: Europe Market Value (US$ Mn) Analysis by End User, 2017-2032 Figure 94: Europe Market Value Share (%) and BPS Analysis by End User, 2022-2032 Figure 95: Europe Market Y-o-Y Growth (%) Projections by End User, 2022-2032 Figure 96: Europe Market Attractiveness by Chemical Nature, 2022-2032 Figure 97: Europe Market Attractiveness by Dosage Type, 2022-2032 Figure 98: Europe Market Attractiveness by Functionality, 2022-2032 Figure 99: Europe Market Attractiveness by End User, 2022-2032 Figure 100: Europe Market Attractiveness by Country, 2022-2032 Figure 101: East Asia Market Value (US$ Mn) by Chemical Nature, 2022-2032 Figure 102: East Asia Market Value (US$ Mn) by Dosage Type, 2022-2032 Figure 103: East Asia Market Value (US$ Mn) by Functionality, 2022-2032 Figure 104: East Asia Market Value (US$ Mn) by End User, 2022-2032 Figure 105: East Asia Market Value (US$ Mn) by Country, 2022-2032 Figure 106: East Asia Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 107: East Asia Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 108: East Asia Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 109: East Asia Market Value (US$ Mn) Analysis by Chemical Nature, 2017-2032 Figure 110: East Asia Market Value Share (%) and BPS Analysis by Chemical Nature, 2022-2032 Figure 111: East Asia Market Y-o-Y Growth (%) Projections by Chemical Nature, 2022-2032 Figure 112: East Asia Market Value (US$ Mn) Analysis by Dosage Type, 2017-2032 Figure 113: East Asia Market Value Share (%) and BPS Analysis by Dosage Type, 2022-2032 Figure 114: East Asia Market Y-o-Y Growth (%) Projections by Dosage Type, 2022-2032 Figure 115: East Asia Market Value (US$ Mn) Analysis by Functionality, 2017-2032 Figure 116: East Asia Market Value Share (%) and BPS Analysis by Functionality, 2022-2032 Figure 117: East Asia Market Y-o-Y Growth (%) Projections by Functionality, 2022-2032 Figure 118: East Asia Market Value (US$ Mn) Analysis by End User, 2017-2032 Figure 119: East Asia Market Value Share (%) and BPS Analysis by End User, 2022-2032 Figure 120: East Asia Market Y-o-Y Growth (%) Projections by End User, 2022-2032 Figure 121: East Asia Market Attractiveness by Chemical Nature, 2022-2032 Figure 122: East Asia Market Attractiveness by Dosage Type, 2022-2032 Figure 123: East Asia Market Attractiveness by Functionality, 2022-2032 Figure 124: East Asia Market Attractiveness by End User, 2022-2032 Figure 125: East Asia Market Attractiveness by Country, 2022-2032 Figure 126: South Asia & Pacific Market Value (US$ Mn) by Chemical Nature, 2022-2032 Figure 127: South Asia & Pacific Market Value (US$ Mn) by Dosage Type, 2022-2032 Figure 128: South Asia & Pacific Market Value (US$ Mn) by Functionality, 2022-2032 Figure 129: South Asia & Pacific Market Value (US$ Mn) by End User, 2022-2032 Figure 130: South Asia & Pacific Market Value (US$ Mn) by Country, 2022-2032 Figure 131: South Asia & Pacific Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 132: South Asia & Pacific Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 133: South Asia & Pacific Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 134: South Asia & Pacific Market Value (US$ Mn) Analysis by Chemical Nature, 2017-2032 Figure 135: South Asia & Pacific Market Value Share (%) and BPS Analysis by Chemical Nature, 2022-2032 Figure 136: South Asia & Pacific Market Y-o-Y Growth (%) Projections by Chemical Nature, 2022-2032 Figure 137: South Asia & Pacific Market Value (US$ Mn) Analysis by Dosage Type, 2017-2032 Figure 138: South Asia & Pacific Market Value Share (%) and BPS Analysis by Dosage Type, 2022-2032 Figure 139: South Asia & Pacific Market Y-o-Y Growth (%) Projections by Dosage Type, 2022-2032 Figure 140: South Asia & Pacific Market Value (US$ Mn) Analysis by Functionality, 2017-2032 Figure 141: South Asia & Pacific Market Value Share (%) and BPS Analysis by Functionality, 2022-2032 Figure 142: South Asia & Pacific Market Y-o-Y Growth (%) Projections by Functionality, 2022-2032 Figure 143: South Asia & Pacific Market Value (US$ Mn) Analysis by End User, 2017-2032 Figure 144: South Asia & Pacific Market Value Share (%) and BPS Analysis by End User, 2022-2032 Figure 145: South Asia & Pacific Market Y-o-Y Growth (%) Projections by End User, 2022-2032 Figure 146: South Asia & Pacific Market Attractiveness by Chemical Nature, 2022-2032 Figure 147: South Asia & Pacific Market Attractiveness by Dosage Type, 2022-2032 Figure 148: South Asia & Pacific Market Attractiveness by Functionality, 2022-2032 Figure 149: South Asia & Pacific Market Attractiveness by End User, 2022-2032 Figure 150: South Asia & Pacific Market Attractiveness by Country, 2022-2032 Figure 151: MEA Market Value (US$ Mn) by Chemical Nature, 2022-2032 Figure 152: MEA Market Value (US$ Mn) by Dosage Type, 2022-2032 Figure 153: MEA Market Value (US$ Mn) by Functionality, 2022-2032 Figure 154: MEA Market Value (US$ Mn) by End User, 2022-2032 Figure 155: MEA Market Value (US$ Mn) by Country, 2022-2032 Figure 156: MEA Market Value (US$ Mn) Analysis by Country, 2017-2032 Figure 157: MEA Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 158: MEA Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 159: MEA Market Value (US$ Mn) Analysis by Chemical Nature, 2017-2032 Figure 160: MEA Market Value Share (%) and BPS Analysis by Chemical Nature, 2022-2032 Figure 161: MEA Market Y-o-Y Growth (%) Projections by Chemical Nature, 2022-2032 Figure 162: MEA Market Value (US$ Mn) Analysis by Dosage Type, 2017-2032 Figure 163: MEA Market Value Share (%) and BPS Analysis by Dosage Type, 2022-2032 Figure 164: MEA Market Y-o-Y Growth (%) Projections by Dosage Type, 2022-2032 Figure 165: MEA Market Value (US$ Mn) Analysis by Functionality, 2017-2032 Figure 166: MEA Market Value Share (%) and BPS Analysis by Functionality, 2022-2032 Figure 167: MEA Market Y-o-Y Growth (%) Projections by Functionality, 2022-2032 Figure 168: MEA Market Value (US$ Mn) Analysis by End User, 2017-2032 Figure 169: MEA Market Value Share (%) and BPS Analysis by End User, 2022-2032 Figure 170: MEA Market Y-o-Y Growth (%) Projections by End User, 2022-2032 Figure 171: MEA Market Attractiveness by Chemical Nature, 2022-2032 Figure 172: MEA Market Attractiveness by Dosage Type, 2022-2032 Figure 173: MEA Market Attractiveness by Functionality, 2022-2032 Figure 174: MEA Market Attractiveness by End User, 2022-2032 Figure 175: MEA Market Attractiveness by Country, 2022-2032
Recommendations
Explore Healthcare Insights
View Reports